Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC 2022 | Highlights from WCLC 2022 in radiation oncology

Michael MacManus • 8 Aug 2022
WCLC 2022
Lung Cancer Non-Small Cell Lung Cancer

Michael MacManus, MBBch, MD, MRCP, Peter MacCallum Cancer Centre, Melbourne, Australia shares his highlights from the IASLC 2022 World Conference on Lung Cancer congress in radiation oncology specifically for oligometastic disease. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.

More from Michael MacManus

1:07
Remaining questions regarding mechanisms of response to immunotherapy in NSCLC
Michael MacManus • 7 Aug 2022
5:14
Increased PD-L1 tracer update in recently-irradiated lesions in NSCLC
Michael MacManus • 7 Aug 2022

Related Videos

2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals